News & Updates
Showing Multidisciplinary articles
Showing

Post-ICH antiplatelet therapy not linked to recurrent ICH
Initiating antiplatelet therapy following an intracerebral haemorrhage (ICH) that occurred during antithrombotic use does not lead to recurrent symptomatic ICH, according to extended results of the RESTART* trial.

ULTIMATE: Biologic DMARD affords inflammation control in psoriatic arthritis
Interleukin-17 inhibition with the biologic disease-modifying antirheumatic drug (DMARD) secukinumab appears to produce a substantial reduction in synovitis in psoriatic arthritis, in addition to improvements in the signs and symptoms of the disease, according to the results of the phase III ULTIMATE.

Modified dual therapy on par with recommended regimen in H. pylori infection
A modified dual therapy as first-line treatment for H. pylori infection demonstrates equal efficacy and compliance relative to recommended regimens, reveals a study. Moreover, a generally modified dual therapy has fewer side effects.

Dietary ALA intake may lower risks of all-cause, CVD, CHD mortality
Dietary intake of alpha linolenic acid (ALA) appears to reduce the risk of mortality from all causes, cardiovascular disease (CVD), and coronary heart disease (CHD) but may slightly increase the risk of cancer mortality, according to a systematic review and meta-analysis. Moreover, an association exists between higher blood levels of ALA and a lower risk of all-cause and CHD mortality.

Healthy diet can improve well-being of adults with multiple sclerosis
A healthier overall diet score and higher fibre, fruit, and vegetable scores result in better health outcomes in adults with multiple sclerosis (MS), according to a study, noting a much lower proportion of participants avoiding dairy and meat or adhering to a specific MS diet than previously reported.

Online symptom checkers unreliable for COVID-19 triage
Though promising, coronavirus disease 2019 (COVID-19) symptom checkers—online, patient-led triage systems—are unable to reliably distinguish mild from severe COVID-19 and may instead put the public and healthcare workers at greater risk of infection, according to a recent study.



